Corsair Capital Management, L.P. Gamida Cell Ltd. Put Options Transaction History

Corsair Capital Management, L.P.

  • $404 Million
  • Q3 2024

Put Options

0 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
No transaction found.

Others Institutions Holding GMDA

# of Institutions
1
Shares Held
2.2K
Call Options Held
0
Put Options Held
0
View Full List

About Gamida Cell Ltd.

GMDA Quotes by TradingView
  • Ticker GMDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,319,600
  • Market Cap $2.29M
  • Description
  • Gamida Cell Ltd., a clinical-stage biopharmaceutical company, develops cell therapies to cure blood cancers and serious hematologic diseases. The company's lead product candidate is omidubicel, a cell therapy that has completed Phase III clinical trial in patients with high-risk hematologic malignancies, as well as in Phase I/II clinical trials ...
More about GMDA
Track This Portfolio

Track Corsair Capital Management, L.P. Portfolio

Follow Corsair Capital Management, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Corsair Capital Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Corsair Capital Management, L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email